NextCure, Inc. (NXTC) — real insider trading activity disclosed to the SEC, tracked automatically as new Form 4 filings are reported. Most recent: ADAR1 Capital Management, LLC — 12 open-market purchases between 2026-07-27 and 2026-07-31, totaling $1,611,833.
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Simcere Zaiming, Inc. | Insider | 2026-08-10 | 30,000 | $184,800 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-31 | 3,300 | $16,420 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-31 | 25,000 | $124,540 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-31 | 8,003 | $38,414 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-30 | 50,000 | $248,615 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-30 | 20,000 | $100,000 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-30 | 25,000 | $120,338 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-30 | 100,000 | $490,000 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-30 | 77,850 | $385,793 |
| ADAR1 Capital Management, LLC | Insider | 2026-07-29 | 1,810 | $9,050 |
Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | RENAISSANCE TECHNOLOGIES LLC reduced this position by 58% ($646,503 -> $273,923). | 2026-06-30 |
| Affinity Asset Advisors, LLC | Affinity Asset Advisors, LLC reduced this position by 97% ($2,582,702 -> $67,136). | 2026-06-30 |
| Squadron Capital Management LLC | Squadron Capital Management LLC reduced this position by 96% ($2,830,200 -> $103,142). | 2026-06-30 |
| Sofinnova Investments, Inc. | Sofinnova Investments, Inc. reduced this position by 85% ($2,377,945 -> $356,246). | 2026-06-30 |
| Ikarian Capital, LLC | Ikarian Capital, LLC reduced this position by 82% ($2,506,947 -> $461,284). | 2026-06-30 |
| SILVERARC CAPITAL MANAGEMENT, LLC | SILVERARC CAPITAL MANAGEMENT, LLC exited a position previously worth $1,880,289. | 2026-06-30 |
| Opaleye Management Inc. | Opaleye Management Inc. exited a position previously worth $1,507,813. | 2026-06-30 |
| AWM Investment Company, Inc. | AWM Investment Company, Inc. exited a position previously worth $1,234,743. | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| Ikarian Capital, LLC | $461,284 | 288,303 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $443,523 | 277,202 |
| Sofinnova Investments, Inc. | $356,246 | 222,654 |
| RENAISSANCE TECHNOLOGIES LLC | $273,923 | 171,202 |
| VANGUARD CAPITAL MANAGEMENT LLC | $250,947 | 156,842 |
| MILLENNIUM MANAGEMENT LLC | $140,979 | 88,112 |
| BOOTHBAY FUND MANAGEMENT, LLC | $135,499 | 84,687 |
| Squadron Capital Management LLC | $103,142 | 64,464 |
| Verdad Advisers, LP | $96,722 | 60,451 |
| Affinity Asset Advisors, LLC | $67,136 | 41,960 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
NextCure, Inc. (NXTC) is showing up on our radar after ADAR1 Capital Management, LLC, a 10%+ owner of the company, made another open-market purchase of the biotech’s shares. On July 31, 2026, ADAR1 bought 3,300 shares at $4.98 apiece, a purchase worth $16,420.14. Following the trade, ADAR1’s indirectly held stake in NextCure stands at 689,416 … Read more